The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in ...
Fogarty’s Cleeland on impact of MedTech innovation; Soriano highlights Baxter’s hurricane response
In this week’s episode of the DeviceTalks Weekly Podcast, Andrew Cleeland, CEO of the Fogarty Institute, shares his MedTech story, starting with a serendipitous move into the industry. Cleeland, of course, went on to lead two successful startups from The Foundry - Ardian and Twelve, that both went on to be acquired by Medtronic. Cleeland now leads one of the industry’s most successful incubator programs, the Fogarty Institute. Cleeland will share insights on leading a MedTech start-up and shares some concerns he has for the industry at large.
The Fogarty Institute is also promoting the Thomas J. Fogarty prize for medical innovation, a $100,000 prize for one person or a small group of people who have broken new ground in the industry. Go to this article at Medical Design & Outsourcing for more information.
https://www.medicaldesignandoutsourcing.com/mike-mussallem-tom-fogarty-prize-medtech-innovation/
Before that conversation, Host Tom Salemi and Holly Scott, managing partner at The Mullings Group, interviewed Cecilia Soriano, global president of Infusion Therapies and Technologies, at Baxter. We’ll preview Soriano’s interview at DeviceTalks Boston where she’ll talk about Baxter’s recovery from Hurricane Helene.
But we’ll start the episode off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers including the FDA, HHS, Alcon, Abbott and Johnson & Johnson MedTech.
Thanks for listening to this episode of the DeviceTalks Weekly podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
--------
1:25:51
Lotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCs
In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes.
Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention & Exhibition Center talks with Salemi and Joe Mullings about the the changes at Zimmer Biomet and in orthopedics.
Register to see Tornos live at Boston.DeviceTalks.com. Use the code mentioned in the podcast to save 25%.
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
--------
1:04:58
BIOTRONIK Neuro’s Langevin talks power of connected spinal stim; What’s Next in Surgical Robotics
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his career in neuro devices, gives his assessment of the field today, explaining how it’s exceeded his early expectations.
Just before that Tom talks with Joe Mullings of The Mullings Group and Surgical Robotics Expert Steve Bell about the state of the surgical robotics industry. The trio will talk about current leaders, emerging powers, and how a shift toward cardiac surgeons could change the playing field completely.
But to start, MassDevice Editor Chris Newmarker joins Tom for the Newmarker’s Newsmakers, the leading stories from the pages of MassDevice. This week’s newsmakers include Tariffs, Medtronic, Surgical Robotics, Stryker, and BCI company Paradromics.
Thank you for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
--------
1:17:26
Will SynCardia's Emperor be capable of boldly going where no artificial heart has gone before?
In this week’s episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia CEO Patrick Schnegelsberg and COO Matthew Schuster. Twenty years after FDA approval, SynCardia is the only company with a commercially available total artificial heart, with more than 2,000 implants. Now they're developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers.
But before the interview Host Tom Salemi gives a quick recap of the MassMedic Symposium and Gala. Then, Chris Newmarker and Senior Editor Danielle Kirsh unpack MassDevice’s new report on surgical robotic companies.
You can download the report for free here. https://www.massdevice.com/gated/massdevices-surgical-robotics-special-report-2025/
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
--------
53:04
Enovis’ Vogt on driving recon growth past $1B w/ M&A, knee breakthroughs and foot & ankle expansion
In the kickoff episode of Season 2 of Ortho Innovation Talks, Louie Vogt, Group President of Reconstructive at Enovis, takes us inside the company’s strategic growth in orthopedics. Vogt shares how Enovis has transformed into a major player in the reconstructive space through key acquisitions and bold bets on innovative implant designs.
He discusses the evolution of knee implants, highlighting Enovis’ pioneering work with kinematically driven bearings and the dual pivot knee concept. Vogt also touches on the growing role of robotics and enabling technologies in orthopedic surgery, emphasizing how these advancements are changing the surgeon experience and patient outcomes.
Beyond knees, Vogt explores Enovis’ expansion into foot and ankle reconstruction—a rapidly growing market—and how the company is leveraging M&A and innovation to carve out a competitive edge. As Enovis looks ahead to 2025, Vogt teases major product launches in shoulders, hips, and extremities, signaling another big year for the company.
This conversation comes to you courtesy of our sponsor, Paragon Medical. To learn more about how Paragon Medical can help you bring your device to market faster, visit them at www.paragonmedical.com.
Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.
WATCH and LISTEN below, thank you for supporting Ortho Innovation Talks!
The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in our diverse and growing portfolio—more than a dozen unique shows featuring senior leaders, groundbreaking technology insights, and in-depth discussions on the most important topics in the medical device industry.
Each episode dives deep into critical areas like business strategy, market trends, surgical robotics, orthopedics, structural heart, neurology, and beyond. You’ll hear from leading voices at top companies—ranging from major OEMs to innovative startups—sharing their solutions, stories, and strategies for tackling the industry’s biggest challenges.
Our Lineup of Shows Includes:
• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neurovascular
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Enovis & Zimmer Biomet
• StrykerTalks
Why Subscribe?
Subscribing here means you’ll never miss an update from any of our shows. Whether you want a broad overview of the entire industry or prefer to tune into a specific series, this single feed has you covered.
If you discover a favorite topic, you can always subscribe to that individual show’s feed for a more tailored experience.
Meet Your Hosts:
• Tom Salemi, Editorial Director, DeviceTalks
• Kayleen Brown, Managing Editor, DeviceTalks
#DeviceTalks, Where Device Makers Connect.
USA